Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?
Correlation of DDLS Grading to OCT, HRT, and HVF
1 other identifier
observational
101
1 country
1
Brief Summary
The purpose of this study is to determine how well the DDLS (Disc Damage Likelihood Scale) (which is a method used by the eye doctor to evaluate how healthy the optic nerve is) measures up to the standard glaucoma tests: OCT (Optical Coherence Tomography), the HRT (Heidelberg Retinal Tomography) and the HVF (Humphrey Visual Field).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2007
CompletedFirst Posted
Study publicly available on registry
February 1, 2007
CompletedStudy Start
First participant enrolled
March 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedNovember 10, 2016
November 1, 2016
1.6 years
January 30, 2007
November 8, 2016
Conditions
Keywords
Study Arms (2)
1: Primary open angle glaucoma
Patients with a form of primary open angle glaucoma
2: No known eye disease (controls)
Patients with no known eye disease (controls)
Eligibility Criteria
glaucoma service
You may qualify if:
- Vision 20/50 or better
- Less than 3 diopters of astigmatism
- diopters or less of myopia or hyperopia
- Pattern Standard Deviation on HVF less than 2.5dB in normals
- Pattern Standard Deviation on HVF greater than 2.5 db in glaucoma patients
You may not qualify if:
- Abnormalities of cornea or ocular media
- Significant ocular pathologies affecting visual field
- History of hypotony
- Ocular surgery within 6 months
- Nystagmus
- Unreliable visual fields
- OCT signal strength scan less than 6
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wills Eyelead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Wills Eye Glaucoma Service
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan S Myers, MD
Wills Eye Glaucoma Service
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Surgeon
Study Record Dates
First Submitted
January 30, 2007
First Posted
February 1, 2007
Study Start
March 1, 2007
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
November 10, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will share
A manuscript has been published.